Circassia Group (CIR)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 24.40p
   
  • Change Today:
      0.000p
  • 52 Week High: 29.10
  • 52 Week Low: 12.93
  • Currency: UK Pounds
  • Shares Issued: 376.91m
  • Volume: 437
  • Market Cap: £91.97m
  • RiskGrade: 7

Circassia shares plunge as its partner terminates agreement

By Josh White

Date: Thursday 19 Dec 2019

LONDON (ShareCast) - (Sharecast News) - Specialty biopharmaceutical company Circassia Pharmaceuticals updated the market on its licensing agreement with BeyondAir, previously AIT Therapeutics, on Thursday.
The AIM-traded firm said the agreement was for the commercial rights to the late-stage ventilator-compatible nitric oxide product 'LungFit PH', previously AirNOvent, in the United States and China.

"Circassia has received a notice from BeyondAir stating that it has terminated the agreement for material breach," the board said in its statement.

"Circassia refutes the allegations in the strongest terms and believes there are no grounds to terminate the agreement.

"The company will enforce its rights under the agreement and defend its position vigorously."

At 1635 GMT, shares in Circassia Pharmaceuticals were down 11% at 18.6p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

CIR Market Data

Currency UK Pounds
Share Price 24.40p
Change Today 0.000p
% Change 0.00 %
52 Week High 29.10
52 Week Low 12.93
Volume 437
Shares Issued 376.91m
Market Cap £91.97m
RiskGrade 7

CIR Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
4.13% above the market average4.13% above the market average4.13% above the market average4.13% above the market average4.13% above the market average
89.29% above the sector average89.29% above the sector average89.29% above the sector average89.29% above the sector average89.29% above the sector average
Price Trend
27.55% above the market average27.55% above the market average27.55% above the market average27.55% above the market average27.55% above the market average
12.28% above the sector average12.28% above the sector average12.28% above the sector average12.28% above the sector average12.28% above the sector average
Income Not Available
Growth
42.71% above the market average42.71% above the market average42.71% above the market average42.71% above the market average42.71% above the market average
54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average

What The Brokers Say

Strong Buy 0
Buy 0
Neutral 0
Sell 0
Strong Sell 1
Total 1
strong_sell
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CIR Dividends

No dividends found

Trades for 08-Jul-2020

Time Volume / Share Price
10:46 9 @ 24.31p
09:24 8 @ 24.43p
09:23 20 @ 24.31p
08:26 400 @ 24.21p

CIR Key Personnel

Chair Francesco Granata
CFO Julien Cotta

Top of Page